The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

NCT00270166 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Multiple Myeloma
Lymphoma
Breast Cancer
Ovarian Cancer
Carcinoma, Small Cell Lung
Esophagus Cancer
Prostate Cancer
Neoplasm

Interventions

DRUG: epoetin alfa

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.